Skip to main content
. 2020 Jan 31;7:4. doi: 10.3389/fnut.2020.00004

Table 3.

Plasma lipid profile.

N WSC CC p
Total cholesterol (mg/dL) 206.0
[178.3; 237.5]
(n = 24)
195.0
[168.0; 246.3]
(n = 16)
179.0
[135.0; 235.0]
(n = 23)
0.372
LDL (mg/dL) 109.0
[92.0; 133.0]
(n = 19)
117.5
[79.5; 139.5]
(n = 10)
95.0
[71.5; 132.0]
(n = 17)
0.584
HHDL (mg/dL) 36.0
[32.0; 42.0]
(n = 19)
45.0
[37.0; 56.0]
(n = 14)
33.0
[30.0; 41.3]#
(n = 20)
0.048
TAG (mg/dL) 164.5
[99.3; 228.8.]
(n = 24)
115.0
[74.3; 158.3]
(n = 16)
96.0
[72.0; 130.0]
(n = 23)
0.138
Glycerol (mg/ml) 0.014
[0.006; 0.022]
(n = 25)
0.003
[0.001; 0.017] (n = 15)
0.004
[0.003; 0.009]*
(n = 22)
0.013
FFA (mg/dL) 0.95
[0.791; 1.18]
(n = 25)
0.95
[0.691; 1.27]
(n = 15)
1.09
[0.890; 1.41]
(n = 22)
0.349
FFA/TAG (%) 0.006
[0.004; 0.009]
(n = 24)
0.008
[0.006; 0.010] (n = 15)
0.011
[0.007; 0.015]
(n = 22)
0.080
FFA/Glycerol (%) 70.0
[38.22; 131]
(n = 25)
232
[41.1; 446]
(n = 15)
179
[99.6; 254]
(n = 22)
0.097

Data are expressed as median [1st quartile; 3rd quartile], p, significance level Kruskal-Wallis test.

TAG, triacylglycerol; LDL, low density lipoprotein; HDL, high-density lipoprotein; FFA, free fatty acid.

*

Significant difference vs. N (p < 0.05).

#

Significant difference vs. WSC (p < 0.05).

p < 0.05 are highlighted in bold.